Theriva Biologics (formerly Synthetic Biologics) is a clinical-stage company that develops oncolytic virus therapeutics. It focuses on immune modulation to treat conditions with limited therapeutic options, such as pancreatic cancer, colorectal cancer, and other solid tumors.